Hebert Peter
Insider CIK 1683771 · MRAM Director · RXRX · AEVA 10% owner · SNCE 10% owner · MTTR Director, 10% owner · LUXA 10% owner · LTCH 10% owner · EIKN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 796,380 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 2,502,252 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 7,807,026 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 530,920 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 3,526,215 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 303,360 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 1,450,614 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 10,266,152 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 5,289,322 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-06 | 2026-02-06 | 10,000,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 2,387,705 | — | $0 | 2,387,705 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 1,151,540 | — | $0 | 1,290,428 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-06 | 2026-02-06 | 2,155,765 | — | $0 | 2,294,653 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 138,888 | $18.00 | $2.50M | 138,888 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 138,888 | $18.00 | $2.50M | 138,888 | SEC↗ |
| MTTR Matterport, Inc./DE | D To issuer deriv | 2025-02-28 | 2025-03-03 | 39,325 | — | $0 | 0 | SEC↗ |
| MTTR Matterport, Inc./DE | D To issuer | 2025-02-28 | 2025-03-03 | 279,793 | — | $0 | 0 | SEC↗ |
| MTTR Matterport, Inc./DE | A Award deriv | 2024-06-10 | 2024-06-12 | 39,325 | — | $0 | 39,325 | SEC↗ |
| MTTR Matterport, Inc./DE | M Exercise deriv | 2024-06-10 | 2024-06-12 | 60,763 | — | $0 | 0 | SEC↗ |
| MTTR Matterport, Inc./DE | P Buy | 2023-08-16 | 2023-08-18 | 50,000 | $2.50 | $125.0K | 279,793 | SEC↗ |
| MTTR Matterport, Inc./DE | A Award deriv | 2023-06-27 | 2023-06-29 | 60,763 | — | $0 | 60,763 | SEC↗ |
| MTTR Matterport, Inc./DE | M Exercise deriv | 2023-06-13 | 2023-06-14 | 38,126 | — | $0 | 0 | SEC↗ |
| MTTR Matterport, Inc./DE | M Exercise deriv | 2023-06-13 | 2023-06-29 | 38,126 | — | $0 | 0 | SEC↗ |
| MTTR Matterport, Inc./DE | M Exercise | 2023-06-13 | 2023-06-14 | 38,126 | — | $0 | 267,919 | SEC↗ |
| AEVA Aeva Technologies, Inc. | J Other | 2022-08-05 | 2022-08-09 | 7,346,159 | — | $0 | 14,692,316 | SEC↗ |
| MTTR Matterport, Inc./DE | A Award deriv | 2022-07-06 | 2023-06-29 | 38,126 | — | $0 | 38,126 | SEC↗ |
| MTTR Matterport, Inc./DE | A Award deriv | 2022-07-06 | 2022-07-11 | 38,126 | — | $0 | 38,126 | SEC↗ |
| SNCE Science 37 Holdings, Inc. | J Other | 2022-04-04 | 2022-04-06 | 2,914,667 | — | $0 | 8,743,999 | SEC↗ |
| MTTR Matterport, Inc./DE | P Buy | 2022-02-24 | 2022-02-28 | 20,000 | $6.38 | $127.6K | 229,793 | SEC↗ |
| MTTR Matterport, Inc./DE | J Other | 2022-01-18 | 2022-01-21 | 6,306,411 | — | $0 | 18,919,230 | SEC↗ |
| MTTR Matterport, Inc./DE | J Other | 2022-01-18 | 2022-01-21 | 209,793 | — | $0 | 209,793 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | J Other | 2021-12-07 | 2021-12-09 | 4,265,576 | — | $0 | 13,021,519 | SEC↗ |
| LTCH Latch, Inc. | J Other | 2021-09-28 | 2021-10-05 | 1,358,164 | — | $0 | 4,084,493 | SEC↗ |
| LTCH Latch, Inc. | J Other | 2021-09-28 | 2021-10-05 | 2,409,489 | — | $0 | 7,228,469 | SEC↗ |
| AEVA Aeva Technologies, Inc. | J Other | 2021-09-08 | 2021-09-10 | 7,346,159 | — | $0 | 22,038,475 | SEC↗ |
| LUXA Lux Health Tech Acquisitio | P Buy deriv | 2020-10-29 | 2020-11-02 | 5,933,333 | $1.50 | $8.90M | 5,933,333 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | A Award | 2020-05-19 | 2020-05-20 | 20,131 | — | $0 | 29,131 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | A Award deriv | 2019-05-21 | 2019-05-22 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | A Award | 2019-05-21 | 2019-05-22 | 6,000 | — | $0 | 9,000 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | A Award deriv | 2018-05-21 | 2018-05-22 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | A Award | 2018-05-21 | 2018-05-22 | 3,000 | — | $0 | 3,000 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion deriv | 2016-10-13 | 2016-10-17 | 118,606 | — | $0 | 0 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion deriv | 2016-10-13 | 2016-10-17 | 219,916 | — | $0 | 0 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion deriv | 2016-10-13 | 2016-10-17 | 0 | — | $0 | 0 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion deriv | 2016-10-13 | 2016-10-17 | 0 | — | $0 | 0 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | P Buy | 2016-10-13 | 2016-10-17 | 137,420 | $8.00 | $1.10M | 1,015,550 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion | 2016-10-13 | 2016-10-17 | 89,946 | $6.40 | $575.7K | 878,130 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion | 2016-10-13 | 2016-10-17 | 131,719 | $6.40 | $843.0K | 788,184 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion | 2016-10-13 | 2016-10-17 | 118,606 | — | $0 | 656,465 | SEC↗ |
| MRAM EVERSPIN TECHNOLOGIES INC | C Conversion | 2016-10-13 | 2016-10-17 | 219,916 | — | $0 | 537,859 | SEC↗ |